Chongqing Lummy Pharmaceutical Co., Ltd. (SHE:300006)
China flag China · Delayed Price · Currency is CNY
5.09
+0.12 (2.41%)
Feb 3, 2026, 3:04 PM CST

SHE:300006 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
Cash & Equivalents
1,0461,072836.44846.29559.43544.91
Cash & Short-Term Investments
1,0461,072836.44846.29559.43544.91
Cash Growth
-4.44%28.18%-1.16%51.28%2.67%24.77%
Accounts Receivable
267.38286.67339.21348.39445.38533.16
Other Receivables
147.19166.75268.73312.52539.13286.8
Receivables
414.57453.42607.94660.9984.51819.96
Inventory
171.97201.7171202.4157.77296.65
Prepaid Expenses
5.1211.33.582.664.57.4
Other Current Assets
33.9931.5727.2133.2320.7827.87
Total Current Assets
1,6711,7701,6461,7451,7271,697
Property, Plant & Equipment
256.13274.92286.97339.92392.49459.97
Long-Term Investments
384.73378.28519.68522.71481.36608.12
Goodwill
44.9544.9532.9432.9432.9438.86
Other Intangible Assets
188.79181.83189.3184.11116.36155.74
Long-Term Accounts Receivable
--34.0632.41--
Long-Term Deferred Tax Assets
134.38128.24132.35116.58104.6292.72
Long-Term Deferred Charges
45.5740.3627.2463.3762.5381.75
Other Long-Term Assets
36.5437.1322.1517.649.4713.85
Total Assets
2,7622,8562,8913,0552,9273,148
Accounts Payable
81.0665.6237.949.6334.2669.39
Accrued Expenses
23.25110.77107.55110.39109.24130.78
Short-Term Debt
297.46242.91113.5121.51301,026
Current Portion of Long-Term Debt
139.12102.752458-106.8
Current Portion of Leases
-3.654.2630.255.4197.16
Current Income Taxes Payable
9.31.312.127.877.031.86
Current Unearned Revenue
13.2213.7917.8524.0413.0724.68
Other Current Liabilities
255.04260.8255.09299.51317.8244.28
Total Current Liabilities
818.45801.61562.27701.14666.81,701
Long-Term Debt
65.7141.45126.5149-59.7
Long-Term Leases
2.33.832.536.5733.9136.87
Long-Term Unearned Revenue
4.836.296.399.0412.2613.43
Long-Term Deferred Tax Liabilities
19.0419.2919.264.471.684.81
Other Long-Term Liabilities
--51.76---
Total Liabilities
910.32972.47768.71870.22714.651,916
Common Stock
1,0561,0561,0561,0561,056812.24
Additional Paid-In Capital
1,4851,4831,4831,4751,459630.4
Retained Earnings
-539.25-501.33-414.9-406.22-358.52-271.32
Comprehensive Income & Other
-162.53-162.53-43.77---
Total Common Equity
1,8391,8752,0812,1242,1561,171
Minority Interest
13.328.0441.5160.5255.7860.29
Shareholders' Equity
1,8521,8832,1222,1852,2121,232
Total Liabilities & Equity
2,7622,8562,8913,0552,9273,148
Total Debt
504.58494.59270.79365.27219.321,427
Net Cash (Debt)
540.99577.51565.65481.02340.11-882.04
Net Cash Growth
-22.18%2.10%17.59%41.43%--
Net Cash Per Share
0.510.550.540.460.34-1.09
Filing Date Shares Outstanding
1,0561,0561,0561,0561,0561,056
Total Common Shares Outstanding
1,0561,0561,0561,0561,056812.24
Working Capital
852.78968.491,0841,0441,060-4.58
Book Value Per Share
1.741.781.972.012.041.44
Tangible Book Value
1,6051,6491,8581,9072,007976.72
Tangible Book Value Per Share
1.521.561.761.811.901.20
Buildings
-411.75413.99412.67412.67455.54
Machinery
-652.83646.2674.06664.11695.91
Construction In Progress
-72.463.784.0916.84
Source: S&P Global Market Intelligence. Standard template. Financial Sources.